Study visits | V0 | V1 | V8 | p valuea | p valuea | p valueb |
---|---|---|---|---|---|---|
(162) | (162) | (162) | V0xV1 | V1xV8 | V0xV1xV8 | |
FVC (L) | 2.5 (2.1–3.2) | 2.7 (2.2–3.3) | 2.4 (1.9–3.0) | <0.01 | <0.01 | <0.00 |
FVC (% pred) | 82.0 (65.0–94.0) | 88.0 (72.0–101.0) | 77.1 (67.1–88.0) | <0.01 | <0.01 | <0.00 |
FEV1 (L) | 1.5 (1.2–2.0) | 1.8 (1.3–2.2) | 1.5 (1.1–2.0) | <0.01 | <0.01 | <0.00 |
FEV1 (%pred) | 59.5 (45–75.8) | 66.5 (54.0–82.3) | 63.0 (49.4–73.4) | <0.01 | <0.01 | <0.00 |
FEV1/FVC | 0.6 (0.5–0.7) | 0.7 (0.5–0.7) | 0.7 (0.6–0.7) | 0.04 | 0.69 | 0.03 |
FEV1/FVC (%pred) | 75.0 (63.8–89.3) | 79.0 (64.8–88.0) | 80.4 (70.1–88.8) | 0.02 | 0.16 | <0.00 |
FEF25–75% (L/s) | 0.5 (0.8–1.3) | 0.9 (0.5–1.7) | 0.8 (0.6–1.4) | <0.01 | 0.04 | <0.01 |
FEF25–75% (%pred) | 27.0 (17.0–48.5) | 33.0 (21.0–52.0) | 34.5 (24.1–51.0) | <0.01 | 0.19 | <0.00 |